Topic - Perrigo

Perrigo Company plc is an American Irish–registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the 6th-largest U.S. corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. - Source: Wikipedia

Related Stories

This image provided by Perrigo Company shows boxes of Opill, the first over-the-counter birth control pill available later this month in the United States. Manufacturer Perrigo said Monday, March 4, 2024 that it has begun shipping the medication, called Opill, to major retailers and pharmacies. (Perrigo Company via AP)

First over-the-counter birth control pill in U.S. begins shipping to stores

By Matthew Perrone - Associated Press

This illustration provided by Perrigo in May 2023, depicts proposed packaging for the company's birth control medication Opill. U.S. officials have approved the first over-the-counter birth control pill, a major change that will broaden access for women and teenagers. The Food and Drug Administration decision on Thursday, July 13, 2023, means drugmaker Perrigo can sell its once-a-day Opill without a prescription. (Perrigo via AP, File)

First over-the-counter birth control pill gets FDA approval

By Matthew Perrone - Associated Press

This illustration provided by Perrigo in May 2023, depicts proposed packaging for the company's birth control medication Opill. U.S. officials have approved the first over-the-counter birth control pill, a major change that will broaden access for women and teenagers. The Food and Drug Administration decision on Thursday, July 13, 2023, means drugmaker Perrigo can sell its once-a-day Opill without a prescription. (Perrigo via AP, File)

FDA approves first over-the-counter birth control pill amid pressure over reproductive rights

By Valerie Richardson - The Washington Times

This illustration provided by Perrigo in May 2023, depicts proposed packaging for the company's birth control medication Opill. Advisers to the Food and Drug Administration meet next week to review drugmaker Perrigo's application to sell a decades-old pill over the counter. The two-day public meeting is one of the last steps before an FDA decision. (Perrigo via AP)

FDA panel backs over-the-counter birth control pill

By Matthew Perrone - Associated Press

This illustration provided by Perrigo in May 2023, depicts proposed packaging for the company's birth control medication Opill. Advisers to the Food and Drug Administration meet next week to review drugmaker Perrigo's application to sell a decades-old pill over the counter. The two-day public meeting is one of the last steps before an FDA decision. (Perrigo via AP)

FDA weighing 1st over-the-counter birth control pill

By Matthew Perrone - Associated Press

Perrigo breaking ground on North American HQ in Michigan

Associated Press